ABCL
Price
$5.90
Change
-$0.08 (-1.34%)
Updated
Oct 3 closing price
Capitalization
1.76B
31 days until earnings call
AXON
Price
$706.22
Change
-$9.29 (-1.30%)
Updated
Oct 6, 11:13 AM (EDT)
Capitalization
56.17B
31 days until earnings call
Interact to see
Advertisement

ABCL vs AXON

Header iconABCL vs AXON Comparison
Open Charts ABCL vs AXONBanner chart's image
AbCellera Biologics
Price$5.90
Change-$0.08 (-1.34%)
Volume$9.11M
Capitalization1.76B
Axon Enterprise
Price$706.22
Change-$9.29 (-1.30%)
Volume$648
Capitalization56.17B
ABCL vs AXON Comparison Chart in %
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. AXON commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a StrongBuy and AXON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (ABCL: $5.90 vs. AXON: $715.51)
Brand notoriety: ABCL and AXON are both not notable
ABCL represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: ABCL: 175% vs. AXON: 61%
Market capitalization -- ABCL: $1.76B vs. AXON: $56.17B
ABCL [@Biotechnology] is valued at $1.76B. AXON’s [@Aerospace & Defense] market capitalization is $56.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $314.95B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B. The average market capitalization across the [@Aerospace & Defense] industry is $23.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileAXON’s FA Score has 2 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • AXON’s FA Score: 2 green, 3 red.
According to our system of comparison, AXON is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 6 TA indicator(s) are bullish while AXON’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 6 bullish, 4 bearish.
  • AXON’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than AXON.

Price Growth

ABCL (@Biotechnology) experienced а +24.47% price change this week, while AXON (@Aerospace & Defense) price change was +0.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +4.93%. For the same industry, the average monthly price growth was +12.83%, and the average quarterly price growth was +77.49%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 06, 2025.

AXON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (+4.93% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($56.2B) has a higher market cap than ABCL($1.76B). ABCL YTD gains are higher at: 101.365 vs. AXON (20.391). AXON has higher annual earnings (EBITDA): 341M vs. ABCL (-197.92M). AXON has more cash in the bank: 2.23B vs. ABCL (553M). ABCL has less debt than AXON: ABCL (142M) vs AXON (2.05B). AXON has higher revenues than ABCL: AXON (2.39B) vs ABCL (32.9M).
ABCLAXONABCL / AXON
Capitalization1.76B56.2B3%
EBITDA-197.92M341M-58%
Gain YTD101.36520.391497%
P/E RatioN/A177.47-
Revenue32.9M2.39B1%
Total Cash553M2.23B25%
Total Debt142M2.05B7%
FUNDAMENTALS RATINGS
AXON: Fundamental Ratings
AXON
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
10
SMR RATING
1..100
57
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLAXON
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
61%
MACD
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
68%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSFCX12.720.11
+0.87%
Touchstone Small Cap C
MGQSX18.250.11
+0.61%
Morgan Stanley Inst Global Stars R6
EISAX30.600.16
+0.53%
Carillon ClariVest Intl Stock A
MTCKX48.990.04
+0.08%
MFS Technology R1
TSNIX62.98-0.38
-0.60%
T. Rowe Price Science & Tech I

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-1.34%
RXRX - ABCL
57%
Loosely correlated
-0.54%
VCYT - ABCL
56%
Loosely correlated
+1.04%
CRSP - ABCL
54%
Loosely correlated
-6.98%
ABSI - ABCL
53%
Loosely correlated
-4.79%
AXON - ABCL
51%
Loosely correlated
-0.70%
More